CV Sciences DEF 14A: Executive Compensation Details
Ticker: CVSI · Form: DEF 14A · Filed: Apr 15, 2025 · CIK: 1510964
| Field | Detail |
|---|---|
| Company | Cv Sciences, Inc. (CVSI) |
| Form Type | DEF 14A |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards
Related Tickers: CVSI
TL;DR
CV Sciences dropped its 2025 proxy statement detailing exec pay. Check out equity awards for 2024.
AI Summary
CV Sciences, Inc. filed a DEF 14A on April 15, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted, vested, and outstanding for their "Peo" (principal executive officer) and "NonPeo" (non-principal executive officers) for the years 2022, 2023, and 2024.
Why It Matters
This filing provides transparency into how CV Sciences, Inc. compensates its top executives, which can influence investor decisions and perceptions of company management.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing providing information on executive compensation and does not inherently present new financial risks.
Key Players & Entities
- CV Sciences, Inc. (company) — Filer of the DEF 14A
- 0000950170-25-054326 (filing_id) — Accession number for the filing
- 20250415 (date) — Filing date
- 2024-12-31 (date) — Fiscal year end for compensation data
FAQ
What is the primary purpose of this DEF 14A filing by CV Sciences, Inc.?
The primary purpose is to provide detailed information regarding the compensation of the company's named executive officers and directors for the fiscal year ending December 31, 2024.
What specific types of compensation are detailed in this filing?
The filing details equity awards, including those granted, vested, and outstanding, along with their fair value calculations for the fiscal years 2022, 2023, and 2024.
Who are the key individuals or groups whose compensation is reported?
The compensation reported is for the company's "Peo" (principal executive officer) and "NonPeo" (non-principal executive officers).
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on April 15, 2025.
What was the previous name of CV Sciences, Inc.?
CV Sciences, Inc. was formerly known as CannaVEST Corp. until February 5, 2013, and prior to that, Foreclosure Solutions, Inc. until January 24, 2011.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 15, 2025 regarding CV Sciences, Inc. (CVSI).